(Total Views: 309)
Posted On: 11/23/2020 4:37:36 AM
Post# of 653
$RLFTF RELIEF ANNOUNCES NOTICE OF EXTRAORDINARY GENERAL MEETING OF RELIEF THERAPEUTICS HOLDING AG 23 November 2020
Geneva, Switzerland, November 23, 2020 – RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) ("Relief" or the "Company"
, a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced clinical development to treat severe COVID-19 patients, today gives notice of an Extraordinary General Meeting (EGM) of shareholders to be held on December 17, 2020. (cont'd)
https://relieftherapeutics.com/newsblog/relie...holding-ag
Geneva, Switzerland, November 23, 2020 – RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) ("Relief" or the "Company"
, a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced clinical development to treat severe COVID-19 patients, today gives notice of an Extraordinary General Meeting (EGM) of shareholders to be held on December 17, 2020. (cont'd) https://relieftherapeutics.com/newsblog/relie...holding-ag
(0)
(0)
$MJ
